In the Kaplan–Meier analysis, patients with baseline blood mucin-1 levels ≥2.5 mg/mL had a significantly higher probability of experiencing AE-IPF during the follow-up (Figure 3a). The gene discussed is MUC1; the disease is idiopathic pulmonary fibrosis.